Lei Jiang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Nephrology top 2%
Papers in
- Nephrology 17
- Acute Kidney Injury Research 8
-
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 10
Lei Jiang
237 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 180
- Cancer Research 736
- Nephrology 262
- Molecular Biology 2.3k
- Immunology 603
- Pathology and Forensic Medicine 346
Countries citing papers authored by Lei Jiang
This map shows the geographic impact of Lei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Jiang more than expected).
Fields of papers citing papers by Lei Jiang
This network shows the impact of papers produced by Lei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Jiang. The network helps show where Lei Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 33 | |
| 11 | 2022 | 11 | |
| 12 | 2020 | 17 | |
| 13 | 2020 | 42 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 3 | |
| 16 | 2018 | 1 | |
| 17 | 2018 | 74 | |
| 18 | 2016 | 118 | |
| 19 | A Robust and Efficient Timestamp-based Remote User Authentication Scheme with Smart Card Lost Attack Resistance. | 2013 | 19 |
| 20 | 2011 | 10 |
About Lei Jiang
Lei Jiang is a scholar working on Nephrology, Cancer Research, Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine, having authored 248 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (11 papers), Forensic and Genetic Research (10 papers), MicroRNA in disease regulation (10 papers), Molecular Biology Techniques and Applications (10 papers), RNA Interference and Gene Delivery (9 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Acute Kidney Injury Research (8 papers). The work is most often cited by research in Cancer Research (736 citations), Nephrology (262 citations), Molecular Biology (2.3k citations), Immunology (603 citations) and Pathology and Forensic Medicine (346 citations). Lei Jiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mingyan Zhao, Guohan Hu, Shangha Pan, Mingran Zhao, Jinming Gao, Kai Kang, Pengcheng He, Minghui Li, Ning Tan and Du Feng. Their work appears in journals such as PLoS ONE, Cochrane Database of Systematic Reviews, Acta Pharmacologica Sinica, BMJ Open and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.